Therapeutics and COVID-19: living guideline
World Health Organization (WHO)

Jan 14th, 2022 - The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.

The Australian living guidelines for the clinical care of people with COVID-19: What wo...
PloS One; Turner T, Elliott J et. al.

Jan 8th, 2022 - The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team ...

Posters - Casirivimab and Imdevimab for COVID-19
World Health Organization (WHO)

Jan 4th, 2022 - Active against alpha, beta, gamma, and delta variants of concern. Consider local epidemiological data since emerging evidence predicts decreased efficacy against Omicron.

Recommendations of the National Comprehensive Cancer Network® (NCCN®) Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis*
National Comprehensive Cancer Network® (NCCN®)

Jan 4th, 2022 - The committee endorses vaccination for all eligible persons based on FDA-approved indications or emergency use authorization (EUA). With the widespread availability of highly effective and safe vaccines, the committee reiterates the need for patients with cancer to be fully immunized, including receiving third doses and boosters.

Clinical Implications of Mask Wearing During Exercise in Inpatient Rehabilitation Setti...
Archives of Physical Medicine and Rehabilitation; Covert K

Dec 30th, 2021 - Clinical Implications of Mask Wearing During Exercise in Inpatient Rehabilitation Setting During COVID-19 Global Pandemic.|2021|Covert K,|

Living guidance for clinical management of COVID-19
World Health Organization (WHO)

Nov 23rd, 2021 - The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Presentation
US Food and Drug Administration (FDA)

Oct 15th, 2021 - On February 27, 2021, FDA issued an Emergency Use Authorization for the Janssen COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The Janssen COVID-19 vaccine, also referred to as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S prot...

2021 update of the EULAR points to consider on the use of immunomodulatory therapies in...
Annals of the Rheumatic Diseases; Alunno A, Najm A et. al.

Oct 9th, 2021 - To update the EULAR points to consider (PtCs) on the use of immunomodulatory therapies in COVID-19. According to the EULAR standardised operating procedures, a systematic literature review up to 14 July 2021 was conducted and followed by a consensus meeting of an international multidisciplinary task force. The new statements were consolidated by formal voting. We updated 2 overarching principle...

CDC Statement on ACIP Booster Recommendations
Centers for Disease Control and Prevention (CDC)

Sep 24th, 2021 - Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings. The Food and Drug Administration’s (FDA) authorization and CDC’s guidance ...

Mass Critical Care Surge Response During COVID-19: Implementation of Contingency Strate...
Chest Dichter JR, Devereaux AV et. al.

Sep 10th, 2021 - After the publication of a 2014 consensus statement regarding mass critical care during public health emergencies, much has been learned about surge responses and the care of overwhelming numbers of patients during the COVID-19 pandemic. Gaps in prior pandemic planning were identified and require modification in the midst of ongoing surges throughout the world. The Task Force for Mass Critical ...

Decision Conditions of Authorisation for COVID-19 Vaccine AstraZeneca (Regulation 174)
GOV.UK Medicines & Healthcare Products Regulatory Agency

Sep 9th, 2021 - This temporary Authorisation under Regulation 174 permits the supply to and by the Crown of COVID-19 Vaccine AstraZeneca, based on the safety, quality and efficacy data submitted by AstraZeneca (AZ) to MHRA in the period from 24/09/2020 to 29/12/2020 December 2020.

Recommendations for Prevention and Control of Influenza in Children, 2021-2022.

Sep 9th, 2021 - This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of the influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021-2022 season. Influenza vaccination is an important intervention to protect vulnerable populations and reduce the burden of respiratory illnesses during circulati...

American Society of Hematology living guidelines on the use of anticoagulation for thro...
Blood Advances; Cuker A, Tseng EK et. al.

Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19-related critical illness who do n...

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency U...
Clinical Chemistry; Zhang YV, Wiencek J et. al.

Sep 2nd, 2021 - The clinical laboratory continues to play a critical role in managing the coronavirus pandemic. Numerous US Food and Drug Administration emergency use authorization (EUA) and laboratory-developed test (LDT) serologic assays have become available. The performance characteristics of these assays and their clinical utility continue to be defined in real time during this pandemic. The AACC convened...

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rhe...
Arthritis & Rheumatology (Hoboken, N.J.); Curtis JR, Johnson SR et. al.

Aug 5th, 2021 - To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the...

Real-World Diagnostic Performance of RSNA Consensus Reporting Guidelines for Findings R...
AJR. American Journal of Roentgenology; Hammer MM

Aug 5th, 2021 - This study evaluated the real-world diagnostic performance of Radiological Society of North America COVID-19 consensus reporting guidelines among 2618 chest CT reports from the author's health care network from April 2020 through March 2021; reverse-transcriptase polymerase chain reaction served as the reference. Typical findings exhibited sensitivity of 68% and specificity of 91%, similar to p...

COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
American College of Obstetricians and Gynecologists (ACOG)

Jul 30th, 2021 - This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group in collaboration with Laura E. Riley, MD; Richard Beigi, MD; Denise J. Jamieson, MD, MPH; Brenna L. Hughes, MD, MSc; Geeta Swamy, MD; Linda O’Neal Eckert, MD; Mark Turrentine, MD; and Sarah Carroll, MPH.

ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidu...
European Journal of Endocrinology; Christ-Crain M, Hoorn EJ et. al.

Jul 23rd, 2021 - COVID-19 has changed the nature of medical consultations, emphasizing virtual patient counselling, with relevance for patients with diabetes insipidus (DI) or hyponatraemia. The main complication of desmopressin treatment in DI is dilutional hyponatraemia. Since plasma sodium monitoring is not always possible in times of COVID-19, we recommend to delay the desmopressin dose once a week until aq...

Customizing local and systemic therapies for women with early breast cancer: the St. Ga...
Annals of Oncology : Official Journal of the European Soc... Burstein HJ, Curigliano G et. al.

Jul 10th, 2021 - The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on ...

Therapeutic Management of Nonhospitalized Adults With COVID-19
National Institutes of Health (NIH)

Jul 8th, 2021 - Figure 1 outlines the COVID-19 Treatment Guidelines Panel’s (the Panel) recommendations for using therapeutic interventions outside the hospital inpatient setting. These recommendations differ depending on the patient’s disposition.